Septerna Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Septerna Inc
Access all reports
Septerna Inc. is a biotechnology company focused on the discovery and development of innovative therapies targeting G protein-coupled receptors (GPCRs). The company leverages proprietary technology to design small molecule therapeutics aimed at addressing unmet medical needs across various disease areas. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Septerna Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Septerna Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Septerna Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SEPN
Country
🇺🇸 United States